S21-400 Chemically Modified Bacterial Peptidoglycan Compositions and Uses thereof Technology Reference CZ Biohub SF ref. no. CZB-231S Stanford ref. no. S21-400 Researchers at Stanford have developed a new microparticle vaccine scaffold for the development of immunogenic subunit vaccines. Peter Kim Carolyn Bertozzi Frances Rodriguez-Rivera Payton Weidenbacher
S18-206 A STRATEGY FOR CREATING VACCINES TO ELICIT ANTIBODIES TARGETING A SPECIFIC EPITOPE Researchers at Stanford, funded in part by the Chan Zuckerberg Biohub, have developed PMD (Protect, Modify, Deprotect), an immunofocusing strategy that can be used in vaccine development for the generation of antibodies targeting a specific epitope. Peter Kim Payton Weidenbacher